Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 258

1.

Frequent detection of acute HIV infection in pregnant women.

Patterson KB, Leone PA, Fiscus SA, Kuruc J, McCoy SI, Wolf L, Foust E, Williams D, Eron JJ, Pilcher CD.

AIDS. 2007 Nov 12;21(17):2303-8.

PMID:
18090278
2.

HIV testing and prophylaxis to prevent mother-to-child transmission in the United States.

American Academy of Pediatrics Committee on Pediatric AIDS.

Pediatrics. 2008 Nov;122(5):1127-34. doi: 10.1542/peds.2008-2175.

PMID:
18977995
3.

HIV infection and zidovudine use in childbearing women.

Sia J, Paul S, Martin RM, Cross H.

Pediatrics. 2004 Dec;114(6):e707-12. Epub 2004 Nov 15.

PMID:
15545619
4.

Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort.

Peters V, Liu KL, Dominguez K, Frederick T, Melville S, Hsu HW, Ortiz I, Rakusan T, Gill B, Thomas P.

Pediatrics. 2003 May;111(5 Pt 2):1186-91.

PMID:
12728136
5.

Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties.

Fiscus SA, Adimora AA, Schoenbach VJ, Lim W, McKinney R, Rupar D, Kenny J, Woods C, Wilfert C.

JAMA. 1996 May 15;275(19):1483-8.

PMID:
8622222
6.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Siegfried N, van der Merwe L, Brocklehurst P, Sint TT.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. Review.

PMID:
21735394
7.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003510. Review. Update in: Cochrane Database Syst Rev. 2011;(7):CD003510.

PMID:
17253490
8.

[Estimate of HIV-1 infection prevalence in pregnant women and effectiveness of zidovudine administered during pregnancy in the prevention of vertical transmission].

Ramos Amador JT, Contreras JR, Bastero R, Barrio C, Moreno P, Delgado R, Muñoz E, Jiménez J.

Med Clin (Barc). 2000 Mar 4;114(8):286-91. Spanish.

PMID:
10774515
9.

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Sturt AS, Dokubo EK, Sint TT.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Review.

PMID:
20238370
10.

Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.

Mofenson LM, Lambert JS, Stiehm ER, Bethel J, Meyer WA 3rd, Whitehouse J, Moye J Jr, Reichelderfer P, Harris DR, Fowler MG, Mathieson BJ, Nemo GJ.

N Engl J Med. 1999 Aug 5;341(6):385-93.

11.

Routine voluntary antenatal anti-HIV screening in Bangkok, Thailand.

Phuapradit W, Chaturachinda K, Saropala N, Chittacharoen A, Sirinavin S, Kunakorn M.

Aust N Z J Obstet Gynaecol. 1995 May;35(2):168-72.

PMID:
7677680
12.

Outcomes and challenges of scaling up comprehensive PMTCT services in rural Swaziland, Southern Africa.

Bancheno WM, Mwanyumba F, Mareverwa J.

AIDS Care. 2010 Sep;22(9):1130-5. doi: 10.1080/09540121003615079.

PMID:
20824565
13.

A decision analysis of mandatory compared with voluntary HIV testing in pregnant women.

Nakchbandi IA, Longenecker JC, Ricksecker MA, Latta RA, Healton C, Smith DG.

Ann Intern Med. 1998 May 1;128(9):760-7.

PMID:
9556471
14.

Effectiveness of intensive nurse case management in decreasing vertical transmission of human immunodeficiency virus infection in Wisconsin.

Havens PL, Cuene BE, Hand JR, Gern JE, Sullivan BW, Chusid MJ.

Pediatr Infect Dis J. 1997 Sep;16(9):871-5.

PMID:
9306482
15.

[Detection of HIV infection in pregnant women by rapid testing: a successful strategy to reduce its vertical transmission].

Quian J, Visconti A, Gutiérrez S, Galli A, Maturo M, Galeano V, Serra M, Lioni M.

Rev Chilena Infectol. 2005 Dec;22(4):321-6. Epub 2005 Dec 5. Spanish.

16.

Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.

Lallemant M, Jourdain G, Le Coeur S, Mary JY, Ngo-Giang-Huong N, Koetsawang S, Kanshana S, McIntosh K, Thaineua V; Perinatal HIV Prevention Trial (Thailand) Investigators.

N Engl J Med. 2004 Jul 15;351(3):217-28. Epub 2004 Jul 9.

17.

Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.

Mandelbrot L, Landreau-Mascaro A, Rekacewicz C, Berrebi A, Bénifla JL, Burgard M, Lachassine E, Barret B, Chaix ML, Bongain A, Ciraru-Vigneron N, Crenn-Hébert C, Delfraissy JF, Rouzioux C, Mayaux MJ, Blanche S; Agence Nationale de Recherches sur le SIDA (ANRS) 075 Study Group.

JAMA. 2001 Apr 25;285(16):2083-93.

PMID:
11311097
18.
19.

Trends in interventions to reduce perinatal human immunodeficiency virus type 1 transmission in North Carolina.

Fiscus SA, Adimora AA, Funk ML, Schoenbach VJ, Tristram D, Lim W, McKinney R, Rupar D, Woods C, Wilfert C.

Pediatr Infect Dis J. 2002 Jul;21(7):664-8.

PMID:
12237600
20.

Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load.

Dickover RE, Garratty EM, Herman SA, Sim MS, Plaeger S, Boyer PJ, Keller M, Deveikis A, Stiehm ER, Bryson YJ.

JAMA. 1996 Feb 28;275(8):599-605.

PMID:
8594240

Supplemental Content

Support Center